In another sign of biopharma's waning interest in the traditional ex vivo gene therapy approach, CSL Behring is shutti | CSL ...
CSL Ltd (ASX: CSL) shares have slipped 9.77% over the past month, leaving some investors questioning whether the global ...
Motley Fool Australia on MSN13d
CSL shares are in the red for 2024. Are they a buy?They are currently swapping hands at $285.30 apiece, down from highs of more than $312 back in July. But despite the recent ...
They've hired CSL International, with offices in New York, Minneapolis and the Dallas area, to survey folks on amenities and ...
Brokers continue to weigh in. The post Are CSL shares a buy after the biotech's FY25 forecasts? appeared first on The Motley ...
The Chiefs are in detailed financial conversations regarding sites in Kansas and Missouri, including their current one at the ...
The Kansas City Chiefs have hired a third-party research firm to conduct market research as part of the club's ongoing ...
Shares of Carlisle Companies Incorporated (NYSE:CSL – Get Free Report) have been given an average rating of “Moderate Buy” by ...
US stocks tumbled as the “Trump bump” that Wall Street got from last week’s presidential election, along with a cut to ...
The Kansas City Chiefs have hired a research group to aid in helping the team determine the future home of the organization.
It is hard to get excited after looking at CSL's (ASX:CSL) recent performance, when its stock has declined 5.3% ...
The 2025 M4 CS acts as the “GT3 Touring” of the M4 range in its lineup placement philosophy, combining the juggernaut ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback